Eutilex.Co.,Ltd (KOSDAQ: 263050)
South Korea
· Delayed Price · Currency is KRW 2,080.00
0.00 (0.00%)
Nov 18, 2024, 3:19 PM KST
Eutilex.Co.,Ltd Company Description
Eutilex.Co.,Ltd. discovers and develops immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases.
It develops anti-tumor T cell therapy and antibody therapeutics. The company was founded in 2015 and is headquartered in Seoul, South Korea.
Eutilex.Co.,Ltd
| Country | South Korea |
| Founded | 2015 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 141 |
Contact Details
Address: Ace Hansol Tower Seoul, 08591 South Korea | |
| Phone | 82 2 3402 7315 |
| Website | eutilex.com |
Stock Details
| Ticker Symbol | 263050 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |